Clopidogrel Protects Endothelium by Hindering TNFα-Induced VCAM-1 Expression through CaMKKβ/AMPK/Nrf2 Pathway.
about
Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention.The Role of Nrf2 in Cardiovascular Function and Disease.Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models.Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects.Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
P2860
Clopidogrel Protects Endothelium by Hindering TNFα-Induced VCAM-1 Expression through CaMKKβ/AMPK/Nrf2 Pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@ast
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@en
type
label
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@ast
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@en
prefLabel
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@ast
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@en
P2093
P2860
P356
P1476
Clopidogrel Protects Endotheli ...... ough CaMKKβ/AMPK/Nrf2 Pathway.
@en
P2093
Huabing Yang
Pengjun Zhao
Shiliu Tian
P2860
P304
P356
10.1155/2016/9128050
P577
2015-12-28T00:00:00Z